BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19414935)

  • 1. Complement and hyper acute rejection.
    Al-rabia MW
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):362-9. PubMed ID: 19414935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifiers of complement activation for prevention of antibody-mediated injury to allografts.
    Hughes PD; Cohney SJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):425-33. PubMed ID: 21681097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies, isotypes and complement in allograft rejection.
    Böhmig GA; Bartel G; Wahrmann M
    Curr Opin Organ Transplant; 2008 Aug; 13(4):411-8. PubMed ID: 18685338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increasing complexity of understanding rejection.
    Hall BM
    Curr Opin Organ Transplant; 2009 Feb; 14(1):1-3. PubMed ID: 19337138
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of complement in graft rejection after organ transplantation.
    Bos IG; Ten Berge IJ; Hack CE
    Transfus Med Rev; 2002 Jul; 16(3):251-64. PubMed ID: 12075562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of immune monitoring in solid organ transplantation.
    Daniel V; Opelz G
    Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects and rejection in solid organ versus reconstructive transplantation.
    Hautz T; Brandacher G; Zelger B; Gorantla VS; Lee AW; Pratschke J; Schneeberger S
    Transplant Proc; 2010 Nov; 42(9):3347-53. PubMed ID: 21094778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection and acceptance of corneal allografts.
    Klebe S; Coster DJ; Williams KA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in transplant rejection: diagnostic and mechanistic considerations.
    Baldwin WM; Ota H; Rodriguez ER
    Springer Semin Immunopathol; 2003 Sep; 25(2):181-97. PubMed ID: 12955466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of chemokines in transplant graft arterial disease.
    Shimizu K; Mitchell RN
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1937-49. PubMed ID: 18802020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant update.
    Parrott N
    Br J Theatre Nurs; 1996 Aug; 6(5):39-42. PubMed ID: 8850869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New faces of acute rejection in 2008].
    Legendre C
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S297-300. PubMed ID: 19596353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the definition and management of high-risk organ transplant recipients.
    Hricik DE
    Curr Opin Organ Transplant; 2009 Dec; 14(6):634-5. PubMed ID: 19920762
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic assays for rejection and tolerance in organ transplantation.
    Bradley BA
    Transpl Immunol; 2005 Aug; 14(3-4):193-201. PubMed ID: 15982563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cells in organ transplantation: Friends or foes?
    Rifle G; Mousson C; Hervé P
    Transplantation; 2006 Jul; 82(1 Suppl):S4-5. PubMed ID: 16829795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts.
    Mendicino M; Liu M; Ghanekar A; He W; Koscik C; Shalev I; Javadi M; Turnbull J; Chen W; Fung L; Sakamoto S; Marsden P; Waddell TK; Phillips MJ; Gorczynski R; Levy GA; Grant D
    Circulation; 2005 Jul; 112(2):248-56. PubMed ID: 15998670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
    Terasaki PI; Cai J
    Transplantation; 2008 Aug; 86(3):377-83. PubMed ID: 18698239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.